Started production of sterile eye drops and expanded operations into Saudi Arabia, the biggest market in the Middle East
Completed the 2 nd expansion resulting in the launch of 3 new production lines including the highly innovative eye ointment line in addition to oral preparations and dermatology lines
Beginning of a New Era in management of the company
Launch of the Nasal Spray production line.
Total revenue was doubled in the course of 3 years.
Company converted from LLC to PSC paving the way for capital increase
Introducing the 7th production line, the innovative BOV Completion of the 3rd expansion introducing 3 new production lines Establishing Photo Voltaic green alternative energy source International Red Cross accreditation and shipping to Geneva 6 new in-licensing agreements Penetrating new geographies (CIS, North & Central Africa, NGO)
Stayed resilient across an unprecedented pandemic and overcame COVID-19.
Was able to achieve double-digit growth Completed Production area renovation project.
Purchased new 6,000m² land for future expansion Increased capacity of the Sterile Eye Drops Line Established Cosmetics Line & Oral Gel Line
Obtained USFDA Drug Establishment
Registration and Signed a tech transfer agreement with Hikma and
Registration of the first multidose preservative free eye drops in the region
